Sept 25 (Reuters) - BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United States, the obesity drug developer said on Wednesday, in a sign of strong demand from investors. The Richmond, California-based company is now seeking to raise as much as $199.5 million by offering 10.5 million shares at...

(Reuters) - Merrill Lynch, Pierce, Fenner & Smith Inc. and Harvest Volatility Management LLC have agreed to pay a combined $9.3 million to settle U.S. Securities and Exchange Commission charges related to investment limits and fees. According to the SEC, the firms exceeded clients' investment limits over a two-year period beginning in March 2016. Regulators said this led to clients...

10:52 AM EDT, 09/25/2024 (MT Newswires) -- (Updates with statement from Southwest Airlines ( LUV ) in the fourth paragraph.) Southwest Airlines ( LUV ) is planning to reduce its Atlanta flights to 381 weekly flights from 567, according to media reports Wednesday. Starting in April, the company will also trim its destinations from the city to 21 from 37,...

On Wednesday, Emergent BioSolutions Inc. ( EBS ) said it secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox, and mpox product portfolio. What Happened: The order includes the previously disclosed U.S. government contract modification to procure ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live), as well as CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) contract options exercised in 2023 and 2024....